Composite Nutritional Supplement for Glycemic Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current therapies are inadequate for effectively managing metabolic diseases such as diabetes, which are characterized by impaired carbohydrate and fat metabolism, leading to significant health complications and economic burdens.

Innovation Solution

A composition comprising coenzyme Q10, chromium, zinc, magnesium, bitter melon extract, fenugreek extract, cinnamon extract, thiamine, ginger extract, ginseng extract, and copper, formulated as a nutritional supplement to normalize glucose levels and improve glycemic control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current therapies are used for managing metabolic diseases, then treatment is provided, but the therapies are inadequate for effectively managing carbohydrate and fat metabolism

Engineering Contradiction:
Improveeffectiveness of therapyVSAvoidmetabolic management capability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple natural products (bitter melon, fenugreek, cinnamon, ginger, ginseng) with essential minerals (chromium, zinc, magnesium, copper) and coenzyme Q10 into a single composite therapeutic composition. This merging of multiple metabolically active components addresses the inadequacy of current single-therapy approaches by creating a synergistic formulation that simultaneously targets carbohydrate and fat metabolism through multiple mechanisms.

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If a composite composition with multiple ingredients is formulated, then metabolic management efficacy is improved, but the composition complexity increases

Engineering Contradiction:
Improveglycemic control efficacyVSAvoidcomposition structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent formulates a composite therapeutic composition integrating multiple natural product extracts and mineral supplements in specific proportions. This composite material approach allows the formulation to achieve enhanced glycemic control and metabolic management efficacy by leveraging the synergistic effects of its diverse components, while the complexity is managed through a unified dosage form.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS20240374538A1Compositions comprising natural products for improving carbohydrate and lipid metabolism
Publication Date: 2024.11.14 GROUPE NATURE PHARMA
  • US20240374538A1 patent drawing
  • US20240374538A1 patent drawing
  • US20240374538A1 patent drawing

AI summary

The present application relates to compositions, nutritional supplements and dosage forms comprising a combination of at least five of the following ingredients: (a) coenzyme Q10; (b) chromium or any pharmaceutically acceptable salt thereof; (c) zinc or any pharmaceutically acceptable salt thereof; (d) magnesium or any pharmaceutically acceptable salt thereof; (e) bitter melon extract; (f) fenugreek extract; (g) cinnamon extract; (h) thiamine; (i) ginger extract; (j) ginseng extract; and (k) copper or any pharmaceutically acceptable salt thereof. The present application also relates to the use of such compositions, nutritional supplements and dosage forms for normalizing glucose levels and for the management of diseases or conditions associated with carbohydrate and lipid metabolism such as diabetes.